PTC Therapeutics, Inc.

PTCT

$64.48

Name : PTC Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $5,122,168,832.00

EPSttm : 7.05

PTC Therapeutics, Inc.

$64.48

0.90%

$0.575

Float Short %

9.59

Margin Of Safety %

-17

Put/Call OI Ratio

0.32

EPS Next Q Diff

-0.3

EPS Last/This Y

12.49

EPS This/Next Y

-10.21

Price

64.46

Target Price

66.27

Analyst Recom

1.94

Performance Q

30.21

Relative Volume

0.81

Beta

0.59

Ticker: PTCT

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-09	PTCT	58.46	0.52	0.75	27531
2025-09-10	PTCT	58.35	0.52	1.33	27524
2025-09-11	PTCT	60.94	0.53	0.02	27556
2025-09-12	PTCT	61.1	0.53	0.12	27475
2025-09-15	PTCT	59.13	0.53	0.16	27517
2025-09-16	PTCT	59.69	0.53	0.14	27557
2025-09-17	PTCT	60.65	0.53783768973642	0	28064
2025-09-18	PTCT	62.87	0.54	0.46	28059
2025-09-19	PTCT	60.49	0.54	0.03	28692
2025-09-22	PTCT	60.85	0.29	2.54	9770
2025-09-23	PTCT	60.56	0.30	2.50	9840
2025-09-24	PTCT	59.5	0.31	23.20	9899
2025-09-25	PTCT	57.85	0.31	1.26	9968
2025-09-26	PTCT	58.97	0.31	0.00	9949
2025-09-29	PTCT	60.65	0.31	0.56	9961
2025-09-30	PTCT	61.39	0.32	0.77	10071
2025-10-01	PTCT	62.04	0.32	1.64	10088
2025-10-02	PTCT	63.04	0.32	0.00	10109
2025-10-03	PTCT	65.4	0.32	0.14	10110
2025-10-06	PTCT	64.8	0.32	0.10	10105
2025-10-07	PTCT	63.95	0.32	0.50	10107
2025-10-08	PTCT	64.49	0.32	0.60	10121
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-09	PTCT	58.43	30.7	-748.2	7.93
2025-09-10	PTCT	58.33	30.7	-750.9	7.93
2025-09-11	PTCT	60.96	30.7	-746.4	7.93
2025-09-12	PTCT	61.10	30.7	-750.5	7.93
2025-09-15	PTCT	58.98	30.7	-753.9	7.93
2025-09-16	PTCT	59.69	30.7	-749.6	7.93
2025-09-17	PTCT	60.68	30.7	-749.1	7.93
2025-09-18	PTCT	62.87	30.7	-747.3	7.93
2025-09-19	PTCT	60.48	30.7	-754.2	7.93
2025-09-22	PTCT	60.85	30.7	-750.1	7.93
2025-09-23	PTCT	60.57	30.7	-751.1	7.93
2025-09-24	PTCT	59.52	30.7	-752.3	7.93
2025-09-25	PTCT	57.84	30.7	-753.3	7.93
2025-09-26	PTCT	58.99	30.7	-748.8	7.93
2025-09-29	PTCT	60.63	30.7	-748.1	7.93
2025-09-30	PTCT	61.40	30.7	-749.6	7.93
2025-10-01	PTCT	62.04	30.7	-749.8	7.93
2025-10-02	PTCT	62.99	30.7	-749.3	7.93
2025-10-03	PTCT	65.38	30.7	-747.3	7.93
2025-10-06	PTCT	64.81	30.7	-748.1	7.93
2025-10-07	PTCT	63.93	35.1	-751.9	7.76
2025-10-08	PTCT	64.46	35.1	-749.9	7.76
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-09	PTCT	-4.78	1.61	8.54
2025-09-10	PTCT	-4.78	1.61	8.54
2025-09-11	PTCT	-5.10	1.61	8.74
2025-09-12	PTCT	-5.10	1.61	8.74
2025-09-15	PTCT	-3.93	1.61	8.74
2025-09-16	PTCT	-4.36	1.61	8.74
2025-09-17	PTCT	-4.36	1.61	8.74
2025-09-18	PTCT	-4.22	1.61	8.74
2025-09-19	PTCT	-3.92	1.61	8.74
2025-09-22	PTCT	-3.92	1.55	8.74
2025-09-23	PTCT	-3.92	1.55	8.74
2025-09-24	PTCT	-3.92	1.55	8.74
2025-09-25	PTCT	-3.92	1.55	9.59
2025-09-26	PTCT	-3.92	1.55	9.59
2025-09-29	PTCT	-3.92	1.54	9.59
2025-09-30	PTCT	-3.92	1.54	9.59
2025-10-01	PTCT	-3.92	1.54	9.59
2025-10-02	PTCT	-3.92	1.54	9.59
2025-10-03	PTCT	-3.92	1.54	9.59
2025-10-06	PTCT	-3.90	1.90	9.59
2025-10-07	PTCT	-3.90	1.90	9.59
2025-10-08	PTCT	-6.98	1.90	9.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.83

Avg. EPS Est. Current Quarter

-0.94

Avg. EPS Est. Next Quarter

-1.13

Insider Transactions

-6.98

Institutional Transactions

1.9

Beta

0.59

Average Sales Estimate Current Quarter

187

Average Sales Estimate Next Quarter

198

Fair Value

53.73

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-73.8

Target Price

66.27

P/E

9.25

Forward P/E

PEG

0.22

P/S

2.9

P/B

P/Free Cash Flow

7.34

EPS

6.97

Average EPS Est. Cur. Y

7.76

EPS Next Y. (Est.)

-2.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

35.65

Relative Volume

0.81

Return on Equity vs Sector %

-329.8

Return on Equity vs Industry %

-316.1

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.17

EBIT Estimation

-749.9

PTC Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 939

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and inflammation and ferroptosis platforms, including vatiquinone to treat Friedreich's ataxia. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. The company has license and collaboration agreement with Novartis Pharmaceuticals Corporation to develop PTC518 Huntington's disease program. It markets Upstaza, a gene therapy with the brand name Kebilidi in the United States. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in Warren, New Jersey.

stock quote shares PTCT – PTC Therapeutics Inc Stock Price stock today

news today PTCT – PTC Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch PTCT – PTC Therapeutics Inc yahoo finance google finance

stock history PTCT – PTC Therapeutics Inc invest stock market

stock prices PTCT premarket after hours

ticker PTCT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: PTCT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y